(4R,5S,8R,9R,11S,12S,13R,18S)-5,11-二羟基-9,16-二甲基-10-羰基-8-(2-羰基-2H-吡喃-5-基)-15,17,20-三氧杂六环[14.3.1.1~14,18~.0~1,13~.0~4,12~.0~5,9~]二十一烷-13-甲醛(non-preferredname) | 98205-50-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 中文名称: (4R,5S,8R,9R,11S,12S,13R,18S)-5,11-二羟基-9,16-二甲基-10-羰基-8-(2-羰基-2H-吡喃-5-基)-15,17,20-三氧杂六环[14.3.1.1~14,18~.0~1,13~.0~4,12~.0~5,9~]二十一烷-13-甲醛(non-preferredname)
• 中文别名: 戴氏伽蓝菜素
• 英文名称: Daigremontianin
• 英文别名: (1S,4R,5S,8R,9R,11S,12S,13R,14R,18S)-5,11-dihydroxy-9,16-dimethyl-10-oxo-8-(6-oxopyran-3-yl)-15,17,20-trioxahexacyclo[14.3.1.114,18.01,13.04,12.05,9]henicosane-13-carbaldehyde
• CAS: 98205-50-6
• 化学式: C₂₆H₃₀O₉
• 分子量: 486.5
• InChiKey: PHOLEJIIASOWOL-LGELPWFGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  35
• 可旋转键数：
  2
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  129
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR UPTAKE AND INTRACELLULAR DELIVERY OF LIPID PARTICLES
  申请人：Lin Paulo J.C.

  公开号：US20120264810A1

  公开（公告）日：2012-10-18

  Compositions, methods and compounds useful for enhancing the uptake of a lipid particle b\ a cell are described In particular embodiments, the methods of the invention include contacting a cell with a lipid particle and a compound that binds a Na+/K+ ATPase to enhance uptake of the lipid particle b\ the cell Related compositions useful in practicing methods include lipid particles comprising a conjugated compound that enhances uptake of the lipid particles b\ the cell The methods and compositions are useful in delivering a therapeutic agent to a cell, e g for the treatment of a disease or disorder in a subject

  描述了用于增强细胞对脂质粒的摄取的组成物、方法和化合物。在特定的实施例中，发明的方法包括将细胞与脂质粒和一种与Na+/K+ ATPase结合的化合物接触，以增强细胞对脂质粒的摄取。在实践方法中使用的相关组成物包括包含一种共轭化合物的脂质粒，该共轭化合物增强细胞对脂质粒的摄取。这些方法和组成物可用于将治疗剂递送到细胞中，例如用于治疗主体中的疾病或失调。
• Lipid-linked prodrugs
  申请人：The University of British Columbia

  公开号：US10780174B2

  公开（公告）日：2020-09-22

  This invention provides lipid-linked prodrugs having structures as set out herein. Uses of such lipid-linked prodrug compounds for treatment of various indications, and methods for making and using lipid-linked prodrugs are also provided.

  本发明提供了具有本文所述结构的脂联原药。本发明还提供了这种脂联原药化合物用于治疗各种适应症的用途，以及脂联原药的制造和使用方法。
• TARGETED OSMOTIC LYSIS OF CANCER CELLS
  申请人：BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE

  公开号：EP2734214A1

  公开（公告）日：2014-05-28
• GENE ENCODING A MUTANT PROTEIN PROVIDING A DECORATIVE FLOWERING PHENOTYPE IN PLANTS
  申请人：Fides B.V.

  公开号：EP3080146A1

  公开（公告）日：2016-10-19
• COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS
  申请人：Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.

  公开号：EP3393477A1

  公开（公告）日：2018-10-31